NEW YORK, Feb. 23 (GenomeWeb News) - CombiMatrix and Benitec announced yesterday that they have entered into a cross-licensing agreement covering a variety of projects.

Through the agreement, CombiMatrix will issue a non-exclusive license to Benitec for its intellectual property rights related to the use of pools of siRNAs, or cocktails, as therapeutic agents against viral diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.